Skip to content

Establishment of rehabilitation prognosis assessment and prediction model for pDOCs of different etiology

Establishment of rehabilitation prognosis assessment and prediction model for pDOCs of different etiology

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073717
Enrollment
Unknown
Registered
2023-07-19
Start date
2023-08-01
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disorders of consciousness

Interventions

Subjects with Disorders of consciousness (Study 1):NA
Subjects with Disorders of consciousness (Study 2):NA

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: ? Male or female patients aged 18-80 years ? The CRS-R assessment and clinical diagnosis of consciousness disorder (including vegetative state/unresponsive awakening syndrome, microconscious state, detachment from microconscious state, silence, etc.) ? =28 days from the onset of disturbance of consciousness ? There are clear causes of consciousness disorders, including brain trauma, cerebral hemorrhage, cerebral infarction, ischemic hypoxic encephalopathy, etc ? The legal guardian agrees and signs the "informed consent" No major chronic diseases, malignant tumors or acute infectious diseases have been confirmed by the researchers ? Stable vital signs, no obvious contraindications.

Exclusion criteria

Exclusion criteria: ? 80 years old ? Acute stage of disturbance of consciousness (onset < 28 days) ? Suffering from severe gastrointestinal, cardiovascular, liver, kidney, blood system, endocrine system, respiratory system disease, immune deficiency, tumor or other serious diseases Candidate subjects have undergone major surgery within the last 3 months; Received an experimental drug or device within 1 month (with unclear efficacy or safety).

Design outcomes

Primary

MeasureTime frame
CSR-R;Thyroid function;Sex hormone;neuron-specific-enolase;Heart rate variability;PRL;

Secondary

MeasureTime frame
pet-ct suv;Event-Related PotentialS;Oxygenate hemoglobin;Deoxygenate hemoglobin, HbR;Blood routine;DDI;

Countries

China

Contacts

Public ContactWu Yi

Huashan Hospital, Fudan University

wuyi@fudan.edu.cn+86 189 3082 8028

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 7, 2026